Share

Test helps doctors identify cause of kidney disease

accreditation
iStock

A new test that helps doctors identify the cause of a specific type of kidney disease has been approved by the US Food and Drug Administration (FDA).

Membranous glomerulonephritis (MGN) damages blood vessels in the kidneys that help filter the blood. Some cases are caused by the body's rejection of its own kidney tissue (autoimmune), while the rest are triggered by other causes such as infection, the FDA said in a news release.

The Euroimmun Anti- Pla2r IFA test detects an antibody that is present if the cause of MGN is autoimmune, the FDA said.

In a clinical study of 560 blood samples, the test detected autoimmune cases of MGN in 77% of samples donated by people presumed to have this form, the agency said.

The test should not be the sole determinant of MGN's cause, nor should a negative test rule out a specific cause, the FDA said.

The test is manufactured by Euroimmun US, based in Morris Plains, New Jersey.

Read more:
Chronic kidney disease on the rise
Exercise safe for kidney disease patients

Chronic kidney disease a warning sign

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE